Valink Therapeutics
YC W21Discovering bispecific antibody drug-conjugates (BsADC) against cancer
Boston, MA, USAFounded 202115 employeeswww.valinktx.com
Team
15
Founded
2021
About
Valink Therapeutics develops next generation antibody-based therapeutics. We identify novel mechanism of action from known targets by incorporating multiple antibody modifications at once, rapidly and scalable generating complex drug candidates (bi-/multispecificity, multivalency and drug-conjugation in a single discovery process). Our research focus is on solid tumours poorly addressed by immunotherapy.
No open roles at this time.
Similar Healthcare startups
PipeBio
PipeBio is a SaaS bioinformatics platform to develop antibody drugs.
AI-powered Drug DiscoveryMachine LearningSaaS
Open Jobs —
Team 10
Founded 2021
AbInitio Bio
The Intelligence layer for Drug Manufacturing
AI-powered Drug DiscoveryBiotechManufacturing
Open Jobs —
Team 2
Founded 2026
1910
Multimodal AI Platform for Modality Agnostic Drug Discovery™
AI-powered Drug Discovery
Open Jobs —
Team 20
Founded 2021
Guardian Bio
Dendritic cell-based platform for cancer therapy
BiotechHealthcareTherapeutics
Open Jobs —
Team 2
Founded 2022